G. Sette

发表

Identification and expansion of the tumorigenic lung cancer stem cell population

M. Biffoni, R. Maria, C. Peschle, 2008, Cell Death and Differentiation.

CD95 death‐inducing signaling complex formation and internalization occur in lipid rafts of type I and type II cells

L. Ricci-Vitiani, M. Todaro, G. Stassi, 2004, European journal of immunology.

Ex Vivo Irradiation of Lung Cancer Stem Cells Identifies the Lowest Therapeutic Dose Needed for Tumor Growth Arrest and Mass Reduction In Vivo

C. Colarossi, R. Giuffrida, S. Forte, 2022, Frontiers in Oncology.

CRIPTO Is a Marker of Chemotherapy-Induced Stem Cell Expansion in Non-Small Cell Lung Cancer

G. Minchiotti, A. Eramo, G. Sette, 2022, Frontiers in Oncology.

Chemotherapy resistance of glioblastoma stem cells

L. Ricci-Vitiani, R. Pallini, L. Larocca, 2006, Cell Death and Differentiation.

Histone acetyltransferase inhibitor CPTH6 preferentially targets lung cancer stem-like cells

S. Carradori, D. Trisciuoglio, A. Mai, 2016, Oncotarget.

Lung Cancer Organoids: The Rough Path to Personalized Medicine

A. Eramo, G. Sette, R. De Maria, 2022, Cancers.

Elimination of quiescent/slow-proliferating cancer stem cells by Bcl-XL inhibition in non-small cell lung cancer

M. Biffoni, M. Todaro, G. Stassi, 2014, Cell Death and Differentiation.

Theratyping cystic fibrosis in vitro in ALI culture and organoid models generated from patient-derived nasal epithelial conditionally reprogrammed stem cells

M. Biffoni, M. Falchi, G. Cimino, 2021, European Respiratory Journal.

Wharton's jelly mesenchymal stromal cells have contrasting effects on proliferation and phenotype of cancer stem cells from different subtypes of lung cancer.

A. Mauro, C. Ciccarelli, A. Martinelli, 2016, Experimental cell research.

Natural compound Tetrocarcin-A downregulates Junctional Adhesion Molecule-A in conjunction with HER2 and inhibitor of apoptosis proteins and inhibits tumor cell growth.

L. Hudson, A. Hopkins, S. Vellanki, 2019, Cancer letters.

EGFR Inhibition Abrogates Leiomyosarcoma Cell Chemoresistance through Inactivation of Survival Pathways and Impairment of CSC Potential

M. Biffoni, L. Memeo, V. Canzonieri, 2012, PloS one.

The kinase inhibitor SI113 induces autophagy and synergizes with quinacrine in hindering the growth of human glioblastoma multiforme cells

P. Matarrese, F. Musumeci, S. Schenone, 2019, Journal of Experimental & Clinical Cancer Research.

Pro-inflammatory gene expression in solid glioblastoma microenvironment and in hypoxic stem cells from human glioblastoma

M. Russo, A. Frati, M. Tafani, 2011, Journal of Neuroinflammation.

Inhibition of DNA methylation sensitizes glioblastoma for tumor necrosis factor-related apoptosis-inducing ligand-mediated destruction.

L. Ricci-Vitiani, R. Pallini, G. Stassi, 2005, Cancer research.

A novel oral micellar fenretinide formulation with enhanced bioavailability and antitumour activity against multiple tumours from cancer stem cells

M. Zucchetti, G. Melino, M. Falchi, 2019, Journal of experimental & clinical cancer research : CR.

A new bioavailable fenretinide formulation with antiproliferative, antimetabolic, and cytotoxic effects on solid tumors

A. Giuliani, G. Melino, A. Bruselles, 2019, Cell Death & Disease.

Conditionally reprogrammed cells (CRC) methodology does not allow the in vitro expansion of patient‐derived primary and metastatic lung cancer cells

R. Pallini, M. Falchi, E. Pilozzi, 2018, International journal of cancer.

Tyr1068-phosphorylated epidermal growth factor receptor (EGFR) predicts cancer stem cell targeting by erlotinib in preclinical models of wild-type EGFR lung cancer

P. Visca, E. Gallo, E. Pilozzi, 2015, Cell Death and Disease.

Therapeutic potential of combined BRAF/MEK blockade in BRAF-wild type preclinical tumor models

A. Scarpa, V. Corbo, S. Shirasawa, 2018, Journal of experimental & clinical cancer research : CR.

Mek inhibition results in marked antitumor activity against metastatic melanoma patient-derived melanospheres and in melanosphere-generated xenografts

M. Biffoni, E. Pilozzi, L. Memeo, 2013, Journal of experimental & clinical cancer research : CR.

The mitogen-activated protein kinase (MAPK) cascade controls phosphatase and tensin homolog (PTEN) expression through multiple mechanisms

R. Maria, J. McCubrey, G. Blandino, 2012, Journal of Molecular Medicine.

Abstracts from the 23rd Italian congress of Cystic Fibrosis and the 13th National congress of Cystic Fibrosis Italian Society

N. Segata, F. Armanini, P. Palange, 2018, Italian Journal of Pediatrics.

PTEN status is a crucial determinant of the functional outcome of combined MEK and mTOR inhibition in cancer

M. Todaro, G. Stassi, M. Konopleva, 2017, Scientific Reports.

Aloe-emodin exerts a potent anticancer and immunomodulatory activity on BRAF-mutated human melanoma cells.

F. Facchiano, C. Tabolacci, A. Lentini, 2015, European journal of pharmacology.

The mitogen-activated protein kinase (MAPK) cascade controls phosphatase and tensin homolog (PTEN) expression through multiple mechanisms

R. Maria, J. McCubrey, G. Blandino, 2012, Journal of molecular medicine.

The kinase inhibitor SI113 induces autophagy and synergizes with quinacrine in hindering the growth of human glioblastoma multiforme cells

P. Matarrese, F. Musumeci, S. Schenone, 2019, Journal of experimental & clinical cancer research : CR.

Therapeutic potential of combined BRAF/MEK blockade in BRAF-wild type preclinical tumor models

A. Scarpa, V. Corbo, S. Shirasawa, 2018, Journal of Experimental & Clinical Cancer Research.

A novel oral micellar fenretinide formulation with enhanced bioavailability and antitumour activity against multiple tumours from cancer stem cells

M. Zucchetti, G. Melino, M. Falchi, 2019, Journal of Experimental & Clinical Cancer Research.

L1077P CFTR pathogenic variant function rescue by Elexacaftor–Tezacaftor–Ivacaftor in cystic fibrosis patient-derived air–liquid interface (ALI) cultures and organoids: in vitro guided personalized therapy of non-F508del patients

V. Villella, S. M. Bruno, A. Eramo, 2023, Respiratory Research.

Wharton's jelly mesenchymal stromal cells have contrasting effects on proliferation and phenotype of cancer stem cells from different subtypes of lung cancer.

A. Mauro, C. Ciccarelli, A. Martinelli, 2016, Experimental cell research.